Table 1 Demographics of schizophrenic patients with different genotypes of PICK1.

From: PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia

Clinical characteristics

rs2076369

rs3952

TT

GT

GG

p

AA

AG

GG

p

Male/Female

13/8

69/51

97/64

0.869

59/38

91/54

29/31

0.149

Age, year

37.10 (10.387)

39.46 (9.390)

37.25 (9.181)

0.130

38.62 (9.401)

38.68 (9.195)

35.95 (9.640)

0.136

Education, year

10.38 (1.564)

10.85 (2.523)

10.99 (2.366)

0.520

10.91 (2.463)

10.91 (2.429)

10.82 (2.167)

0.998

Age at illness onset, year

21.76 (7.245)

24.08 (7.458)

22.70 (5.849)

0.198

23.40 (6.806)

23.41 (6.990)

22.27 (5.480)

0.734

Illness duration, months

184.00 (108.804)

209.05 (373.722)

169.07 (101.021)

0.689

174.27 (106.674)

203.19 (341.497)

163.42 (103.113)

0.486

Antipsychotic dose, mg/day*

527.50 (462.425)

568.54 (643.838)

501.23 (339.773)

0.556

553.26 (716.057)

532.32 (361.405)

485.78 (266.378)

0.355

  1. All data were presented by mean (standard deviation).
  2. Chi-Square test for categorical variables (gender); according to normality of data, Kruskal-Wallis test for continuous variables (except age which was normal distribution, so we used ANOVA test).
  3. *Antipsychotic dose, presented by chlopromazine equivalent dose.